Guest Writer

MiddleGround Capital on unlocking value through automation

The key to successful automation is in relying on, and integrating, the people that make manufacturing processes work, according to John Dotson, managing director of operations at MiddleGround Capital.

National defense industrial strategy: a guide for investors

An increased role for private equity and others outside the traditional ecosystem has been underlined as an imperative to success.

To CV, or not to CV? That is the question!

CVs are an attractive solution for many situations, but other secondary GP liquidity structures might be a better answer, writes W Capital Partners' Todd Miller.

Time to come in from the cold

Six steps private equity sponsors should take now to prepare for a thawing IPO market.

A co-investment blueprint: If you take the leap, do it right

Knowing exactly why you want to co-invest, formalizing your strategy and making sure all the key ingredients are built into your program will go a long way toward making you a reliable, sought-after co-investor, write Meketa Investment Group's Steven Hartt and Ethan Samson.

Value creation in the mid-market

The usual routes to generating value have become less linear than in past years. The macro issues that have emerged are not easy to ignore or navigate, writes Jordan Margolin of VSS Capital Partners.

Staying true to your LPs: Navigating strategy drift in a challenging environment

GPs who have remained prudent in their investment strategies and who didn’t get over their skis in the hype of the bubble have an opportunity to take advantage of this market correction, says Sageview Capital's Amanda Stewart.

The Vistria Group: ‘Optimizing impact is no longer a nice-to-have’

Sophisticated impact measurement and management is a core imperative, not a side hustle, say Kelly McCarthy and Jon Samuels of Vistria Group.

The Vistria Group: Yesterday’s approach to healthcare won’t deliver tomorrow’s results

Innovative strategies from the private sector are required to deliver strong health outcomes for patients across socio-demographics.

Failure to plan for an IPO is planning to fail

With a new year just around the corner and the economy bracing for the Presidential election, those looking to IPO by Q4 2024 must prepare now.